These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 34675617)
1. The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention. Qin Y; Qiao Y; Wang D; Yan G; Tang C; Ma G Int J Gen Med; 2021; 14():6497-6504. PubMed ID: 34675617 [TBL] [Abstract][Full Text] [Related]
2. Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury. Zhang W; Gu Y; Zhou J; Wang J; Zhao X; Deng X; Li H; Yan L; Jiao X; Shao F Ren Fail; 2024 Dec; 46(1):2307959. PubMed ID: 38289005 [TBL] [Abstract][Full Text] [Related]
3. Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis. Abdellatif HAA; Sultan BO; Nassar HM; Gomaa MEE; Sakr MG; Riad E; Al-Harbi AI; Abdulhakim JA; Fawzy MS; Abd El-Fadeal NM Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108340 [TBL] [Abstract][Full Text] [Related]
4. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery. Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of systemic immune-inflammatory index combined with CHA2DS2-VASC score for contrast-induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Zhu Y; Qiu H; Wang Z; Shen G; Li W Int Urol Nephrol; 2023 Nov; 55(11):2897-2903. PubMed ID: 37000380 [TBL] [Abstract][Full Text] [Related]
6. Nomogram Model for Cardiac Surgery-Associated Acute Kidney Injury Based on Clinical Characteristics Combined with Plasma suPAR. Zhu L; Cai J; Fang J; Ran L; Chang H; Zhang H; Zeng J; Yang Q; Fu C; Li Q; Pan Q; Zhao H Int J Gen Med; 2024; 17():3181-3192. PubMed ID: 39049830 [TBL] [Abstract][Full Text] [Related]
7. Urinary semaphorin 3A as an early biomarker to predict contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Ning L; Li Z; Wei D; Chen H; Yang C; Wu D; Wang Y; Zhang J Braz J Med Biol Res; 2018 Mar; 51(4):e6487. PubMed ID: 29513790 [TBL] [Abstract][Full Text] [Related]
8. Predictive value of suPAR in AKI: a systematic review and meta-analysis. Huang Y; Huang S; Zhuo X; Lin M Clin Exp Nephrol; 2023 Jan; 27(1):1-11. PubMed ID: 36469196 [TBL] [Abstract][Full Text] [Related]
9. Soluble Urokinase-Type Plasminogen Activator Receptor Levels as a Predictor of Kidney Replacement Therapy in Septic Patients with Acute Kidney Injury: An Observational Study. Skalec T; Adamik B; Kobylinska K; Gozdzik W J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35330042 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive review and meta-analysis of suPAR as a predictor of acute kidney injury. Jankowski L; Pruc M; Gasecka A; Chmielewski J; Wojcik T; Szarpak L; Kowalczyk M Ann Agric Environ Med; 2023 Jun; 30(2):364-368. PubMed ID: 37387388 [TBL] [Abstract][Full Text] [Related]
15. Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department. Walls AB; Bengaard AK; Iversen E; Nguyen CN; Kallemose T; Juul-Larsen HG; Jawad BN; Hornum M; Andersen O; Eugen-Olsen J; Houlind MB Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577543 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery. Rasmussen SR; Nielsen RV; Møgelvang R; Ostrowski SR; Ravn HB BMC Nephrol; 2021 Apr; 22(1):120. PubMed ID: 33827466 [TBL] [Abstract][Full Text] [Related]
17. Soluble Urokinase Receptor and Acute Kidney Injury. Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687 [TBL] [Abstract][Full Text] [Related]
18. Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention. Andò G; de Gregorio C; Morabito G; Trio O; Saporito F; Oreto G Circ Cardiovasc Interv; 2014 Aug; 7(4):465-72. PubMed ID: 25027519 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases. Loosen SH; Tacke F; Binnebosel M; Leyh C; Vucur M; Heitkamp F; Schoening W; Ulmer TF; Alizai PH; Trautwein C; Koch A; Longerich T; Roderburg C; Neumann UP; Luedde T Oncotarget; 2018 Jun; 9(43):27027-27038. PubMed ID: 29930748 [TBL] [Abstract][Full Text] [Related]
20. The Association of Serum Lactate Level with the Occurrence of Contrast-Induced Acute Kidney Injury and Long-Term Prognosis in Patients Undergoing Emergency Percutaneous Coronary Intervention. Yan G; Wang D; Tang C; Ma G Int J Gen Med; 2021; 14():3087-3097. PubMed ID: 34234537 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]